Boston Scientific Corporation announced that the HI-PEITHO global randomized clinical trial evaluating the use of the Ekos endova ...

Imperative Care, Inc. announced the enrollment of the first patient in the prospective observational CLEAR-IT clinical study ...

Perfuze, an Ireland-based developer of catheters for interventional stroke care, announced it has received FDA 510(k) ...

XCath, a developer of neuroendovascular surgical robotics, announced the completion of the first telerobotic stroke procedure ...

IceCure Medical Ltd. announced positive top-line results from its ICESECRET clinical trial of its ProSense cryoablation ...

Nine leading medical societies have issued a call for updated safety standards in fluoroscopy laboratories, where clinicians ...

Abbott announced that its transcatheter Esprit below-the-knee (BTK) everolimus-eluting resorbable scaffold system has been ...

March 18, 2026—iVascular announced 3-year follow-up results from the LUMIFOLLOW registry, a large real-world study evaluating ...

March 19, 2026—iVascular announced 1-year results from the BARISTA clinical trial, which is evaluating the safety and efficacy of the company&rs ...

Peijia Medical, a China-based domestic medical device company focused on transcatheter valve therapeutics and neurovascular inter ...

Imperative Care, Inc., a developer of treatments for thromboembolic disease, announced the closing of a $100 million ...

Thrombolex, Inc., a commercial-stage developer of a differentiated pharmacomechanical lysis platform for the treatment of ...